5. References

  1. IBM Micromedex® DRUGDEX® (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. Available at: http://www.micromedexsolutions.com.libproxy.uthscsa.edu/ (cited: June 20, 2022). 
  2. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc; 2022. Available at: http://www.clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu. Accessed June 20, 2022.
  3. Aspirin extended-release capsules (Durlaza®) package insert. New Haven Pharmaceuticals, September 2015.
  4. Diclofenac potassium powder for solution (Cambia®) package insert. Assertio Therapeutics, Inc. October 2019.
  5. Diclofenac potassium tablet (Lofena®) package insert. Carwin Pharmaceutical Associates, LLC. November 2021.
  6. Diclofenac potassium tablet (Cataflam®) package insert. Blucrest Pharmaceuticals, LLC. July 2021.
  7. Diclofenac potassium tablets package insert. Mylan Pharmaceuticals, October 2020.
  8. Diclofenac potassium liquid filled capsule (Zipsor®) package insert. Assertio Therapeutics, Inc. April 2021.
  9. Diclofenac capsules (Zorvolex®) package insert. Iroko Pharmaceuticals, LLC, April 2019.
  10. Diflunisal oral tablet package insert. Cadila Healthcare Limited. December 2019.
  11. Etodolac tablets and capsules package insert. Taro Pharmaceuticals U.S.A., Inc. March 2021.
  12. Etodolac extended-release tablets package insert. Northstar RX LLC. May 2021.
  13. Fenoprofen calcium oral capsule (Nalfon®) package insert. Xspire Pharma. May 2021.
  14. Fenoprofen calcium oral tablet (Nalfon®) package insert. Xspire Pharma. May 2021.
  15. Flurbiprofen oral tablet package insert. Teva Pharmaceuticals USA, Inc. November 2021.
  16. Ibuprofen oral tablets product information. Aero Healthcare. April 2022.
  17. Indomethacin oral capsule package insert. Cadila Healthcare Limited. August 2021.
  18. Indomethacin capsules (Tivorbex®) package insert. Iroko Pharmaceuticals, LLC, January 2018.
  19. Indomethacin (Indocin®) package insert. Zyla Life Sciences US Inc. November 2021.
  20. Ketoprofen oral capsule package insert. Misemer Pharmaceuticals, Inc. January 2022.
  21. Ketoprofen extended release oral capsule package insert. Mylan Pharmaceuticals Inc. March 2021.
  22. Meclofenamate oral capsule package insert. Mylan Pharmaceuticals Inc. May 2021.
  23. Mefenamic acid capsules package insert. Belcher Pharmaceuticals, LLC. December 2021.
  24. Meloxicam oral tablet (Mobic ®) package insert. Boehringer Ingelheim Pharmaceuticals, Inc. October 2018.
  25. Meloxicam capsules (Vivlodex®) package insert. Egalet US Inc. April 2021.
  26. Nabumetone oral tablet (Relafen®) package insert. Blucrest Pharmaceuticals LLC. July 2021.
  27. Nabumetone oral tablet (Relafen DS®) package insert. Carwin Pharmaceutical Associates, LLC. May 2022.
  28. Naproxen delayed-release tablets (EC-Naprosyn®), naproxen tablets (Naprosyn®), naproxen sodium tablets (Anaprox®/Anaprox® DS) package insert. Atnahs Pharma US. March 2017.
  29. Naproxen sodium controlled-release tablets (Naprelan®) package insert.  Almatica Pharma. April 2021.
  30. Oxaprozin caplets (Daypro®) package insert. Pfizer. January 2022.
  31. Piroxicam oral capsules (Feldene®) package insert. Pfizer. May 2021.
  32. Salsalate oral tablet package insert. Acella Pharmaceuticals, LLC. January 2020.
  33. Sulindac oral tablet package insert. Actavis Pharma, Inc. September 2021.
  34. Diclofenac sodium/misoprostol tablets (Arthrotec®) package insert. Pfizer. August 2021.
  35. Ibuprofen and famotidine oral tablet (Duexis®) package insert. Horizon Therapeutics USA, Inc. June 2021.
  36. Naproxen and esomeprazole magnesium oral tablet (Vimovo®) package insert. Horizon Therapeutics USA, Inc. March 2022.
  37. Ketorolac (Toradol®) package insert. Roche Pharmaceuticals. March 2013.
  38. Children’s ibuprofen suspension (100 mg/5 ml) product information. Amazon.com Services LLC. November 2021.
  39. AHFS Drug Information 2022. Bethesda, MD: American Society of Health-System Pharmacists. 2022. Available at: http://online.statref.com.ezproxy.lib.utexas.edu/document/F9-IjOEqk3ZluRgZSvZvmt!!. Accessed June 20, 2022. 
  40. Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J. A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly. Aging Dis. 2018;9(1):143-150. 
  41. U.S. Food and Drug Administration. Center for Drug Evaluation and Research. COX-2 selective (includes Bextra, Celebrex, and Vioxx) and non-selective non-steroidal anti-inflammatory drugs (NSAIDs). (February 6, 2018) Available at: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/cox-2-selective-includes-bextra-celebrex-and-vioxx-and-non-selective-non-steroidal-anti-inflammatory. Accessed June 20, 2022.
  42. United States Food and Drug Administration. FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes. (July 9, 2015)  Available at:  http://www.fda.gov/Drugs/DrugSafety/ucm451800.htm. Accessed June 20, 2022.
  43. Joshi GP, Gertler R, Fricker R. Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs. Anesth Analg. 2007;105:1793–804.
  44. Waksman JC, Brody A, Phillips SD. Nonselective nonsteroidal antiinflammatory drugs and cardiovascular risk: are they safe? Ann Pharmacother. 2007;41:1163-73.
  45. Hermann M, Ruschitzka F. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional nonsteroidal anti-inflammatory drugs. Ann Med. 2007;39:18-27.
  46. Friedewald VE, Bennett JS, Christo JP, et al. AJC Editor's consensus: Selective and nonselective nonsteroidal anti-inflammatory drugs and cardiovascular risk. Am J Cardiol. 2010;106(6):873-84.
  47. Lazzaroni M, Battocchia A, Porro GB. COXIBs and non-selective NSAIDs in the gastroenterological setting: What should patients and physicians do?  Dig Liver Dis. 2007;39:589-96.
  48. Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study: a randomized trial. JAMA. 2000;284;1247-55.